Trial Profile
Combination Treatment for Visceral Leishmaniasis Patients Co-infected with Human Immunodeficiency Virus in India.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Nov 2015
Price :
$35
*
At a glance
- Drugs Amphotericin B (Primary) ; Miltefosine (Primary)
- Indications Visceral leishmaniasis
- Focus Therapeutic Use
- 24 Nov 2015 New trial record